These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9917431)

  • 1. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin.
    Martinez JC; Garcia HO; Otheguy LE; Drummond GS; Kappas A
    Pediatrics; 1999 Jan; 103(1):1-5. PubMed ID: 9917431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
    Kappas A; Drummond GS; Munson DP; Marshall JR
    Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Sn-mesoporphyrin.
    Valaes T; Drummond GS; Kappas A
    Pediatrics; 1998 May; 101(5):E1. PubMed ID: 9565434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns.
    Kappas A; Drummond GS; Henschke C; Valaes T
    Pediatrics; 1995 Apr; 95(4):468-74. PubMed ID: 7700742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single dose of Sn-mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns.
    Kappas A; Drummond GS; Valaes T
    Pediatrics; 2001 Jul; 108(1):25-30. PubMed ID: 11433050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin.
    Valaes T; Petmezaki S; Henschke C; Drummond GS; Kappas A
    Pediatrics; 1994 Jan; 93(1):1-11. PubMed ID: 8265301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sn-mesoporphyrin suppression of hyperbilirubinemia in EHBR/Eis rats, an animal model of Dubin-Johnson syndrome.
    Drummond GS; Kappas A
    Pharmacology; 1998 Mar; 56(3):158-64. PubMed ID: 9532616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia.
    Bhutani VK; Poland R; Meloy LD; Hegyi T; Fanaroff AA; Maisels MJ
    J Perinatol; 2016 Jul; 36(7):533-9. PubMed ID: 26938918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant.
    Reddy P; Najundaswamy S; Mehta R; Petrova A; Hegyi T
    J Perinatol; 2003 Sep; 23(6):507-8. PubMed ID: 13679941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tin-mesoporphyrin in the treatment of refractory hyperbilirubinemia due to Rh incompatibility.
    Maisels MJ; Yang H
    J Perinatol; 2012 Nov; 32(11):899-900. PubMed ID: 23128060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive value of umbilical cord blood bilirubin level for subsequent neonatal jaundice].
    Sun G; Wang YL; Liang JF; Du LZ
    Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):848-52. PubMed ID: 18282419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of feeding type on the efficacy of phototherapy.
    Gulcan H; Tiker F; Kilicdag H
    Indian Pediatr; 2007 Jan; 44(1):32-6. PubMed ID: 17277429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates.
    Suresh GK; Martin CL; Soll RF
    Cochrane Database Syst Rev; 2003; (2):CD004207. PubMed ID: 12804504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tin-metalloporphyrins: an answer to neonatal jaundice?
    Steffensrud S
    Neonatal Netw; 1998 Aug; 17(5):11-7; quiz 18-9. PubMed ID: 9791442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tin-mesoporphyrin, a potent heme oxygenase inhibitor, for treatment of intracerebral hemorrhage: in vivo and in vitro studies.
    Wagner KR; Hua Y; de Courten-Myers GM; Broderick JP; Nishimura RN; Lu SY; Dwyer BE
    Cell Mol Biol (Noisy-le-grand); 2000 May; 46(3):597-608. PubMed ID: 10872746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is breastfeeding really favoring early neonatal jaundice?
    Bertini G; Dani C; Tronchin M; Rubaltelli FF
    Pediatrics; 2001 Mar; 107(3):E41. PubMed ID: 11230622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased response to phototherapy for neonatal jaundice in breast-fed infants.
    Tan KL
    Arch Pediatr Adolesc Med; 1998 Dec; 152(12):1187-90. PubMed ID: 9856427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stannsoporfin with phototherapy to treat hyperbilirubinemia in newborn hemolytic disease.
    Rosenfeld WN; Hudak ML; Ruiz N; Gautam S;
    J Perinatol; 2022 Jan; 42(1):110-115. PubMed ID: 34635771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A multicenter randomized controlled study on the efficacy and safety of Yinzhihuang oral solution for the treatment of neonatal indirect hyperbilirubinemia in term newborn infants].
    Clinical Research Collaborative Group of Yinzhihuang Oral Solution
    Zhonghua Er Ke Za Zhi; 2011 Sep; 49(9):663-8. PubMed ID: 22176900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.